Pitch Competition: Building a Biotech Venture program

Loading Events
Online Event Event Link

Learn how the next generation of regenerative medicine researchers at the University of Toronto and its affiliated hospitals are preparing to translate their discoveries toward impact. At the Building a Biotech Venture Pitch Competition, six trainee-led teams will pitch their regenerative medicine-related products or ventures to an expert panel of judges and compete for up to $25,000 in research funding.

The competition is the culmination of Medicine by Design’s Building a Biotech Venture program, offered in partnership with H2i. Over the past three months, the program has offered workshops and mentoring to help teams advance company or product concepts based on their regenerative medicine research. The teams with the highest potential for company creation have been selected to take part in the pitch competition.

Meet the judges

Meet the teams

Dandelion Biologicslogo

Dandelion Biologics provides an advanced antibody development platform for challenging therapeutic targets.

HDAX Therapeuticslogo

HDAX Therapeutics focuses on developing epigenetic-targeting treatments through designing and synthesizing the next generation of life-improving medicines to tackle unmet healthcare needs in cancer and central nervous system disorders.


Laetech harnesses the regenerative capacity of fat to improve the clinical outcomes of cosmetic and reconstructive surgical procedures.


LifeScreen is developing a new approach to personal wellness using biological age.


MyoThera identifies therapeutic targets to boost the impaired regenerative capacity of skeletal muscle in Duchenne muscular dystrophy patients.


PancraTECH is using stem cells to generate a cellular therapy for patients with type 1 diabetes.

Share This Story

Go to Top